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ABSTRACT
Aims/Introduction: To investigate and forecast type 2 diabetes mellitus epidemic, its
related risk factors and cost in Oman by 2050.
Materials and Methods: An age-structured mathematical model was used to charac-
terize type 2 diabetes mellitus epidemiology and trends in Oman between 1990 and
2050. The model was parametrized using current and quality data, including six nationally
representative population-based epidemiological surveys for type 2 diabetes mellitus and
its key risk factors.
Results: The projected type 2 diabetes mellitus prevalence increased from 15.2% in
2020 to 23.8% in 2050. The prevalence increased from 16.8 and 13.8% in 2020 among
women and men to 26.3 and 21.4% in 2050, respectively. In 2020, 190,489 Omanis were
living with type 2 diabetes mellitus compared with 570,227 in 2050. The incidence rate
per 1,000 person-years changed from 8.3 in 2020 to 12.1 in 2050. Type 2 diabetes mellitus’
share of Oman’s national health expenditure grew by 36% between 2020 and 2050 (from
21.2 to 28.8%). Obesity explained 56.7% of type 2 diabetes mellitus cases in 2020 and
71.4% in 2050, physical inactivity explained 4.3% in 2020 and 2.7% in 2050, whereas smok-
ing accounted for <1% of type 2 diabetes mellitus cases throughout 2020–2050. Sensitiv-
ity and uncertainty analyses affirmed these predictions.
Conclusions: The type 2 diabetes mellitus epidemic in Oman is expected to increase
significantly over the next three decades, consuming nearly one-third of the national
health expenditure. The type 2 diabetes mellitus burden is heavily influenced by obesity.
Interventions targeting this single risk factor should be a national priority to reduce and
control the burden of type 2 diabetes mellitus in Oman.
INTRODUCTION
Diabetes mellitus is one of the fastest growing global health
challenges of the 21st century1. Based on the 2019 International
Diabetes Federation (IDF) Diabetes Atlas, 463 million adults
aged 20–79 years (prevalence of 9.6%) are estimated to be liv-
ing with diabetes mellitus today, worldwide, and 700 million
(prevalence of 10.9%) are projected to be living with the
condition by 20451. Specifically, the Middle East and North
Africa (MENA) region is estimated to have the highest diabetes
mellitus prevalence of all regions in both 2019 and 2045 (i.e.,
12.8 and 15.7%, respectively)1.
It is well established that type 2 diabetes mellitus, which
accounts for approximately 90% of all diabetes mellitus cases, is
linked to a variety of non-modifiable and modifiable risk fac-
tors1. Non-modifiable risk factors include age, genetics and
sociodemographic factors2–4, whereas modifiable risk factorsReceived 11 August 2020; revised 23 October 2020; accepted 26 October 2020
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include unhealthy diet, obesity (defined by body mass index
≥30 kg/m2), physical inactivity, tobacco use and alcohol con-
sumption, among others3,5–7.
Oman is one of the 21 countries and territories of the IDF
MENA region, with a population of 4.95 million in 2020, of
which 56% are Omanis8. With diabetes mellitus being a main
concern to policy-makers in Oman, four national and two
regional population-based surveys were carried out to estimate
the diabetes mellitus prevalence and associated cardiovascular
risk factors between 1991 and 20179–15. The surveys reported
an increasing diabetes mellitus prevalence among Omani
nationals ranging between 11 and 15%9–15. The surveys also
reported on the prevalence of key risk factors for diabetes mel-
litus, including obesity, which ranged between 13 and 35%,
tobacco use between 2 and 9%, and physical inactivity between
38 and 42%9–15.
To investigate type 2 diabetes mellitus (not all diabetes melli-
tus cases) epidemiology and its projections in Oman up to
2050, we extended and adapted a recently developed mathe-
matical modeling approach16 and applied it to Oman. A key
strength of this approach is that it factored (as model input)
the totality of existing evidence on type 2 diabetes mellitus and
its risk factors in Oman, to elucidate the epidemiology, and to
generate inferences and predictions. Specifically, we forecasted
the levels and trends in type 2 diabetes mellitus prevalence,
incidence and incidence rate, as well as the prevalence of obe-
sity, tobacco use and physical inactivity up to 2050. We also
estimated the national heath expenditure directly attributed to
type 2 diabetes mellitus, and delineated the epidemiological role
of key risk factors in type 2 diabetes mellitus epidemiology in
Oman.
METHODS
An extension and adaptation of a published type 2 diabetes
mellitus compartmental modeling approach16,17 was utilized to
describe and characterize the dynamics of the type 2 diabetes
mellitus epidemic in the Omani population (only Omani
nationals). Description of the conceptual framework, model
structure, data sources, model fitting and model analyses are
given in Figure 1. Further details on the model can be found
in Awad et al.16. In brief, this dynamical modeling approach, in
contrast to earlier approaches applied to Oman’s type 2 dia-
betes mellitus epidemic12,18–21, captured the interplay between
the natural history of type 2 diabetes mellitus, related risk fac-
tors and demography. The model also stratified the Omani
population by age, sex, and by the general progression states of
susceptible and living with type 2 diabetes mellitus. The suscep-
tible and type 2 diabetes mellitus populations were further
stratified into different compartments according to their risk
factor status including ‘healthy’ (defined as having none of the
included type 2 diabetes mellitus-related risk factors), obesity,
tobacco use (hereafter referred to as smoking), physical inactiv-
ity and the different overlaps between these risk factors
(Figure 1).
Data sources and model fitting
Model input parameters were set based on epidemiological and
natural history data, as described in Figure 1 and listed in
Table S1, or by fitting the model to existing data on demography,
type 2 diabetes mellitus prevalence (assuming all reported dia-
betes mellitus cases were type 2 diabetes mellitus) and type 2 dia-
betes mellitus-related risk factors for Oman. The sex- and age-
specific demographic structure of the Omani nationals was
obtained from the National Center for Statistics and Information
of Oman (Figure S1)8. Sex- and age-specific type 2 diabetes mel-
litus, obesity, smoking, and physical inactivity prevalence data
were obtained from Oman’s four nationally representative popu-
lation-based surveys carried out between 1991 and 20179–11,15, as
well as from two regional community-based surveys carried out
in the Nizwa district in 2001 and 201013,14. The characteristics of
these surveys are summarized in Table S2.
All the nationally representative prevalence measures for
type 2 diabetes mellitus and its risk factors were equally
weighted during model fitting, but the regional prevalence mea-
sures were ‘anchored’ to fit only the prevalence trend, and not
the absolute prevalence level, as they are not nationally repre-
sentative. The latter fitting was implemented per an existing
‘anchoring’ fitting method22,23. The ‘baseline’ type 2 diabetes
mellitus incidence rate (in the absence of risk factors accounted
for in the model), and six other sex- and age-specific transition
rates related to obesity, smoking, and physical inactivity (given
in Figure 1) were derived through the model’s best fit of the
input data.
Projecting the burden of type 2 diabetes mellitus and risk
factors
Using the best fit parameters, the sex- and age-specific preva-
lence of type 2 diabetes mellitus, obesity, smoking, and physical
inactivity were estimated between 1990 and 2050 in the popula-
tion aged 20–79 years . The total number of prevalent and inci-
dent type 2 diabetes mellitus cases (i.e., annual number of new
cases), and overall incidence rate (estimated using the ‘baseline’
incidence rate and the relative risks [RRs] of developing type 2
diabetes mellitus with respect to each key risk factor) were also
predicted for the studied time period. The RRs were based on
pooled global estimates of data from prospective studies5–7 from
multiple settings and countries, as they are related to biological
mechanisms that are probably universal in their effect, such as
the effect of obesity on onset of diabetes. Through a population
attributable fraction approach16,24, the effect of each risk factor
on type 2 diabetes mellitus was also estimated.
To fit the actual obesity trend in the survey data9–15, the age-
specific rate of obesity was allowed to increase (through a logis-
tic function) between 1990 and 2050. Meanwhile, as informed
by the survey data9–15, the age-specific rates of smoking and
physical inactivity were assumed constant throughout the stud-
ied period. Hence, the demographic structure of the population
was the only driving factor of the temporal change in the
prevalence of smoking and physical inactivity.
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Figure 1 | Description of the mathematical modeling methodology applied in the present study. T2DM, type 2 diabetes mellitus.
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Estimating the health expenditure attributed to type 2
diabetes mellitus
Oman’s health expenditure that is directly attributed to type 2
diabetes mellitus was estimated using the J€onsson approach25.
This was carried out by adjusting the per capita health expendi-
ture using the relative ratio (Ras) of all health expenditure of
type 2 diabetes mellitus individuals compared with non-type 2
diabetes mellitus individuals, as informed by the global litera-
ture25,26.
The temporal change in Oman’s per capita health expendi-
ture was based on the observed historical trend between 1998
and 2010, as reported in Oman’s Health Vision 2050 report
(Figure S2)27. Meanwhile, between 2011 and 2050, two scenar-
ios were considered: Oman’s per capita health expenditure was
fixed at its 2010 level (i.e., $US56827), or the observed trend
between 1998 and 2010 was extrapolated into the future (Fig-
ure S2)27. As informed by the international literature25,26, an
Ras between 2 and 3 was applied to bracket the range of type 2
diabetes mellitus-attributable spending. No discounting was
applied for costs.
Sensitivity analyses
Sensitivity analyses were carried out to assess the robustness of
our predictions. In the first analysis, instead of the observed
increase in the age-specific obesity prevalence in Oman’s sur-
veys9–15, this prevalence was assumed to be constant between
2017 and 2050 at its 2016 level (Figure S7a). Hence, the demo-
graphic structure of the population was the only driving factor
of the temporal change in obesity prevalence.
In the second analysis, obesity prevalence was assumed to
grow, but at a slower rate than predicted in the main analysis,
hence reaching an obesity prevalence in 2050 that was 10 per-
centage points lower than that projected in the main analysis
(Figure S7b). This analysis is meant to reflect the impact of an
intervention targeting obesity as part of the national response.
Given the evidence showing that self-reported physical activ-
ity is inflated relative to objective biomarkers28, the third sensi-
tivity analysis assessed the effects of a higher (but reasonable at
75%) prevalence of physical inactivity on type 2 diabetes melli-
tus prevalence (Figure S7c).
Given that the demographic structure in 2040 (i.e., ‘popula-
tion pyramid’), as reported by the National Center for Statistics
and Information of Oman (Figure S8a), is different from that
projected for Oman by the Population Division of the United
Nations Department of Economic and Social Affairs (Fig-
ure S8b)29, the fourth sensitivity analysis assessed the effects of
a demographic structure that is similar to that of the United
Nations Department of Economic and Social Affairs’ projec-
tions29 (by enforcing a declining trend in the birth rate over
the next two decades).
Although the estimates of the RRs of developing type 2 dia-
betes mellitus with respect to each key risk factor and the RR
of mortality with type 2 diabetes mellitus were obtained from
large and quality prospective studies5–7, the robustness of the
model predictions were further assessed through additional uni-
variate sensitivity analyses by varying these RRs (using their
estimated 95% confidence intervals).
Uncertainty analysis
To specify the range of uncertainty in the estimated and pro-
jected type 2 diabetes mellitus outcomes, a multivariable uncer-
tainty analysis of 1,000 runs was carried out. In each
uncertainty run of the model, the key structural model parame-
ters (Table S1), including the RR of mortality and of develop-
ing type 2 diabetes mellitus if obese, a smoker and physically
inactive, were varied simultaneously applying Latin Hypercube
sampling from a multidimensional distribution of the parame-
ters. This sampling technique, implemented in MATLAB
(2019a; MathWorks, Natick, MA, USA) through the function
LHSDESIGN30, is a statistical sampling approach to generate
random samples of the input parameter values, and systemati-
cally uses the information about the whole parameter space in
carrying out the uncertainty runs31. The technique aims to
spread the sampled points evenly across all possible values
within the parameter range31. For parameters with no prior
confidence interval or plausibility range (such as the RR of
mortality), we assumed –30% uncertainty around the parame-
ters’ point estimates, as informed by an existing approach16.
For each set of new input parameter values, the type 2 diabetes
mellitus model was refitted and the 95% uncertainty intervals
(UIs) were calculated for each model outcome.
The mathematical model and all analyses were carried out
using MATLAB 2019a30.
RESULTS
The best fit of the model to the size of the Omani population
is in Figure S1. The best fit of the model to the sex- and age-
specific prevalence data for type 2 diabetes mellitus (Figure S3),
obesity (Figure S4), smoking (Figure S5) and physical inactivity
(Figure S6) across the different surveys is also shown in Sup-
porting information. The model produced good fits to these
data (fitting process was terminated, and goodness of fit
assessed, at a tolerance of 10-4 for the error function30).
Projecting the type 2 diabetes mellitus burden
The model projected an increase in type 2 diabetes mellitus
prevalence from 15.2% (95% UI 14.7–15.7) in 2020 to 18.0%
(95% UI 17.3–18.9) in 2030 and to 23.8% (95% UI 22.5–25.4)
in 2050 (Figures 2a, S10). Type 2 diabetes mellitus prevalence
increased among women from 16.8 to 26.2% between 2020 and
2050. Type 2 diabetes mellitus prevalence increased among
men from 13.8 to 21.4% between 2020 and 2050 (Figure 2a).
For comparison with IDF estimates (please note discussion),
type 2 diabetes mellitus prevalence was also projected for the
years 2019 and 2045 to be 15.0 and 22.5%, respectively.
The number of Omanis living with type 2 diabetes mellitus
was predicted to increase from 190,489 in 2020 to 282,585 in
2030 and to 570,227 in 2050 (Figure 2b), whereas the annual
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Figure 2 | The projected type 2 diabetes mellitus (T2DM) epidemic among Omanis aged 20–79 years, 1990–2050. (a) Type 2 diabetes mellitus
prevalence. (b) Total number of Omanis living with type 2 diabetes mellitus. (c) Type 2 diabetes mellitus incidence rate. (d) Annual number of new
type 2 diabetes mellitus cases.
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number of new type 2 diabetes mellitus cases (i.e., type 2 dia-
betes mellitus incidence) increased from 17,230 to 25,432 and
to 47,559, respectively (Figure 2d). The incidence rate per
1,000 person-years also increased from 8.3 in 2020 to 9.7 in
2030 and to 12.1 in 2050 (Figure 2c). The absolute number of
type 2 diabetes mellitus prevalent and incident cases, as well as
the incidence rate per 1,000 person-years was higher among
Omani women compared with men (Figure 2b–d).
Estimating the health expenditure attributed to type 2
diabetes mellitus
Assuming an Ras of 2–3 and fixed per capita health expenditure
between 2011 and 2050, the total health expenditure attributed
to type 2 diabetes mellitus was estimated to be $97.5–
171.1 million in 2020, $140.1–241.0 million in 2030 and
$267.1–444.5 million in 2050 (Figure 3a). Given the number of
Omanis living with type 2 diabetes mellitus (Figure 2b),
$512.0–898.0, $495.8–852.7 and $468.4–779.5 would be spent
per type 2 diabetes mellitus patient in 2020, 2030 and 2050,
respectively (Figure 3b).
Total health expenditure attributed to type 2 diabetes mellitus
was $119.1–208.9 million in 2020, $233.1–400.9 million in 2030
and $680.7–1,132.9 million in 2050, assuming an Ras of 2–3 and
increased per capita health expenditure between 2011 and 2050
(Figures 3c,S2). Given the number of Omanis living with type 2
diabetes mellitus (Figure 2b), $625.2–1,096.7, $824.9–1,418.6 and
$1,193.8–1,986.8 would be spent per type 2 diabetes mellitus
patient in 2020, 2030 and 2050, respectively (Figure 3d).
For these same years, type 2 diabetes mellitus would con-
sume 12.1–21.2%, 13.8–23.8% and 17.3–28.8% of Oman’s
national health expenditure (Figure 3e).
Projecting the prevalence of obesity, smoking and physical
inactivity
Assuming continuation of the increasing (logistical) trend in
obesity prevalence as per the survey data (Figure S4)9–14, the
model projected an increase in obesity prevalence from 35.9%
in 2020 to 69.1% in 2050 (Figure 4a), with the increase most
pronounced for women (Figure 4a). Smoking and physical
inactivity prevalence remained stable at 6.6 and 35.0%, respec-
tively, between 2020 and 2050 (Figure 4b,c). Women had lower
smoking prevalence (0.3%) than men (12.6% between 2020 and
2050; Figure 4b). Women had higher physical inactivity preva-
lence (~46% between 2020 and 2050) than men (~25% between
2020 and 2050; Figure 4c).
Impact of obesity, smoking and physical inactivity on type 2
diabetes mellitus
The proportion of incident type 2 diabetes mellitus cases attrib-
uted to obesity increased from 56.7% in 2020 to 63.5% in 2030
and to 71.4% in 2050 (Figure 4d). In women, this proportion
was predicted to increase from 67.8 to 80.5% between 2020
and 2050. In men, this proportion was predicted to increase
from 45.5 to 64.1% between 2020 and 2050 (Figure 4d).
The proportion of incident type 2 diabetes mellitus cases
attributed to smoking slightly decreased from 0.6% in 2020 and
2030, to 0.5% in 2050 (Figure 4e). In women, this proportion
remained stable at 0.02% between 2020 and 2050. In men, this
proportion decreased from 1.6 to 1.2% between 2020 and 2050
(Figure 4e).
The proportion of incident type 2 diabetes mellitus cases
attributed to physical inactivity also decreased from 4.3% in
2020 to 3.6% in 2030 and to 2.7% in 2050 (Figure 4f). In
women, this proportion decreased from 4.9 to 3.0% between
2020 and 2050. In men, this proportion decreased from 3.4 to
2.4% between 2020 and 2050 (Figure 4f).
Sensitivity analyses
Figure 5a shows the impact on type 2 diabetes mellitus preva-
lence of assuming that the age-specific obesity prevalence
remained stable after 2017 (Figure S7a). Type 2 diabetes melli-
tus prevalence increased from 15.2% in 2020 to 17.1% in 2050.
In women, type 2 diabetes mellitus prevalence increased from
16.8 to 18.7% between 2020 and 2050. In men, type 2 diabetes
mellitus prevalence increased from 13.7 to 15.6% between 2020
and 2050 (Figure 5a). Type 2 diabetes mellitus incidence rate
per 1,000 person-years flattened at 7.9 between 2020 and 2050
(Figure S9a).
Figure 5b shows the impact on type 2 diabetes mellitus
prevalence of assuming that obesity prevalence increased at a
slower rate compared with the main prediction, hence reach-
ing a prevalence level in 2050 that was 10 percentage points
lower (i.e., 59.1% instead of 69.1% in 2050; Figure S7b).
Type 2 diabetes mellitus prevalence increased from 15.2% in
2020 to 21.0% in 2050. In women, type 2 diabetes mellitus
prevalence increased from 16.8 to 23.4% between 2020 and
2050. In men, type 2 diabetes mellitus prevalence increased
from 13.7 to 18.8% between 2020 and 2050 (Figure 5b). The
type 2 diabetes mellitus incidence rate per 1,000 person-years
increased from 7.8 to 10.9 between 2020 and 2050 (Fig-
ure S9b).
Figure 5c shows the impact on type 2 diabetes mellitus
prevalence of assuming a higher (but stable) physical inactivity
prevalence of 75% (Figure S7c). Type 2 diabetes mellitus preva-
lence increased from 15.2% in 2020 to 24.1% in 2050. In
women, type 2 diabetes mellitus prevalence increased from 16.8
to 26.5% between 2020 and 2050. In men, type 2 diabetes mel-
litus prevalence increased from 13.7 to 21.8% between 2020
and 2050 (Figure 5c). The type 2 diabetes mellitus incidence
rate per 1,000 person-years increased from 8.3 to 12.2 between
2020 and 2050 (Figure S9c).
Figure 5d shows the impact on type 2 diabetes mellitus
prevalence of assuming a demographic structure that is similar
to that projected by the United Nations Department of Eco-
nomic and Social Affairs for Oman29 (by enforcing a declining
trend in the birth rate over the next two decades; Figure S8b).
Type 2 diabetes mellitus prevalence increased from 15.2% in
2020 to 27.2% in 2050. In women, type 2 diabetes mellitus
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prevalence increased from 16.8 to 30.1% between 2020 and
2050. In men, type 2 diabetes mellitus prevalence increased
from 13.7 to 24.3% between 2020 and 2050 (Figure 5d). The
type 2 diabetes mellitus incidence rate per 1,000 person-years
increased from 8.5 to 18.2 between 2020 and 2050 (Fig-
ure S9d).
Figures S9 and S10 provide further sensitivity analyses show-
ing that the projected type 2 diabetes mellitus prevalence is sen-
sitive to the value of the RR of developing type 2 diabetes
mellitus if obese, and the RR of mortality in persons with
type 2 diabetes mellitus compared with the general population.
However, the projected prevalence was insensitive to variations
in the remaining parameters (Figure S10). In 2050, the type 2
diabetes mellitus prevalence ranged from 20.9–26.8% to 22.4–
25.3% by varying (over the 95% confidence interval) the RR of
developing type 2 diabetes mellitus if obese in women and
men, respectively (Figure S10). The type 2 diabetes mellitus
prevalence ranged from 22.9–25.0% to 23.2–24.7% by varying
the RR of mortality with type 2 diabetes mellitus in women
and men, respectively (Figure S10).
Uncertainty analysis
Figure S11 shows the results of the uncertainty analysis for the
trend in type 2 diabetes mellitus prevalence between 1990 and
2050. The range of uncertainty was relatively small, highlighting
that the predicted type 2 diabetes mellitus prevalence was con-
sistent despite the uncertainty in the input parameters. As the
model is constrained by current data, the uncertainty interval
was narrow at current times, but wider as we approached 2050.
DISCUSSION
The type 2 diabetes mellitus prevalence in Oman was projected
to increase within the next decade (2020–2030) by 18.5%, and
further by 31.8% between 2030 and 2050. Over 2020–2050,
Oman will witness a nearly 200% increase in the number of
Omanis living with type 2 diabetes mellitus as a result of a
growing and aging population. This will result in type 2 dia-
betes mellitus consuming 29% of the national health expendi-
ture by the year 2050 (that is $1 out of every $3 spent on
health). Oman currently provides national health services to all
Omanis free of charge, mainly through the oil and gas
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Figure 3 | Projected health expenditure on type 2 diabetes mellitus (T2DM) in Oman, 2020–2050. (a) Total expenditure and (b) expenditure per
type 2 diabetes mellitus case assuming fixed annual per capita health expenditure between 2011 and 2050. (c) Total expenditure and (d)
expenditure per type 2 diabetes mellitus case assuming increasing annual per capita health expenditure between 2011 and 2050 based on
extrapolation of the historical trend27. (e) Proportion of Oman’s total health expenditure spent on type 2 diabetes mellitus. Health expenditure was
calculated as per the J€onsson’s approach25. R is the relative ratio of all health expenditures between individuals with and without type 2 diabetes
mellitus. It is the key parameter for converting the per capita health expenditure to estimates of type 2 diabetes mellitus-attributable spending.
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revenues. However, the volatility of this source of income cou-
pled with the emergence of other global threats, such as the
one recently witnessed due to the coronavirus disease 2019
pandemic, questions the sustainability of current health service
financing (including for diabetes mellitus)27.
The relative roles of smoking and physical inactivity in the
epidemic were forecasted to decline between 2020 and 2050,
despite their prevalences remaining stable, as growing obesity is
the key risk factor that will affect the type 2 diabetes mellitus
epidemic over the next few decades (Figure 4). These findings
show that Oman is confronted with a serious challenge of a
high and increasing type 2 diabetes mellitus epidemic if obesity
is not controlled over the coming years.
Our projections are based on currently available data for the
trends in risk factors and the demographic structure of the pop-
ulation, but future trends could be subject to changes due to
intervention programs, among others. Thus, the projections pro-
vided in the present study should be compared with and vali-
dated with future data coming from nationally representative
population-based surveys for type 2 diabetes mellitus and its risk
factors. Having said so, sensitivity analyses using alternative sce-
narios for the trends in obesity, physical inactivity and demo-
graphic structure affirmed the predicted growing trend in type 2
diabetes mellitus prevalence and incidence, but suggested that
the projected growth of the epidemic could be smaller (by 13–
28%) if the obesity trend stabilizes soon or does not increase
substantially over the coming decades.
Several randomized clinical trials showed the feasibility of
reducing the risk of type 2 diabetes mellitus by 31–58% by tar-
geting individuals at high risk of type 2 diabetes mellitus with
lifestyle interventions, such as diet, exercise or through pharma-
cological (metformin) interventions32–34. Evidence has shown
also that structural interventions targeting obesity, smoking and
physical inactivity have the potential to positively impact the
type 2 diabetes mellitus epidemic35. Such interventions include
increasing taxation on sugar-sweetened beverages (i.e., fiscal
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Figure 4 | Projections for type 2 diabetes mellitus-related risk factors among Omanis, 2020–2050. The figure shows the projected prevalence of (a)
obesity, (b) smoking and (c) physical inactivity, and proportions of type 2 diabetes mellitus cases that are attributable to (d) obesity, (e) smoking
and (f) physical inactivity.
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Figure 5 | Sensitivity analyses. Projected type 2 diabetes mellitus (T2DM) prevalence in Omanis aged 20–79 years, between 1990 and 2050,
assuming (a) the age-specific obesity prevalence remained stable after 2017, (b) lower obesity prevalence than projected in the main analysis
between 2017 and 2050, (c) higher prevalence of physical inactivity than that self-reported in the Omani surveys9–14, and (d) demographic structure
similar to that projected by the Population Division of the United Nations Department of Economic and Social Affairs29.
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Currently, there are no intervention programs in Oman
addressing obesity at the community-level, and health educa-
tional programs or nutritional interventions remain modest36.
The type 2 diabetes mellitus health response includes dedicated
diabetes mellitus clinics at the primary healthcare level with full
access to all medications required to treat type 2 diabetes melli-
tus and associated cardiovascular risk factors, with clear path-
ways for secondary and tertiary referral services. A local
diabetes mellitus registry is also kept in every primary care
clinic acting as a surveillance and screening tool for diabetes
mellitus complications and for annual screening of diabetes
mellitus related complications. Additionally, obesity clinics have
recently been introduced in most primary healthcare facilities.
From June 2019, Oman also introduced an excise tax on all
soda drinks (50% of retail price) and all energy drinks (100%
of retail price), and a 100% tax on all tobacco products37. The
scope of excise taxation is planned to be widened to include all
sugar-containing drinks from October 202038. Yet, it is not
known whether increasing taxation on such products will atten-
uate the type 2 diabetes mellitus epidemic in Oman. Further
considerations and investigations are required to assess the
impact of such interventions.
The percentage increase in type 2 diabetes mellitus preva-
lence projected in the present study was lower than that pro-
jected by the IDF for the duration 2019–2045. Our study
predicted that the type 2 diabetes mellitus prevalence will
increase by 50.0%, whereas the IDF estimated an increase of
67.5%1. These differences might be explained by differences in
the included survey data inputs, as well as differences in the
implemented modeling methodology. We used all survey data
available for Oman, and a dynamical population-level model
for type 2 diabetes mellitus and its key risk factors, whereas the
IDF approach implements a logistic regression method with a
specific criteria for which surveys to be included as input data,
apparently including only one survey from Oman1. Other stud-
ies, using different methodologies, also showed a rapidly grow-
ing type 2 diabetes mellitus epidemic in Oman12,39.
The forecasted increase in the type 2 diabetes mellitus inci-
dence rate in Oman contrasts with the flattening or even
decline seen in the type 2 diabetes mellitus incidence rate in
high-income countries40. A recent systematic review showed
that the type 2 diabetes mellitus incidence rate has flattened or
declined in recent years in a number of high-income coun-
tries40. The main reason behind the different trajectory between
Oman and these countries is the different demographic struc-
ture. The Omani population is young (with a median age of
24 years in 20208), and its aging effect will need to unfold over
several decades, thus driving a higher type 2 diabetes mellitus
incidence rate.
Nevertheless, the forecasted type 2 diabetes mellitus epidemic
in Oman in the present study is similar to that forecasted for
other Gulf countries, such as in Kuwait1, Saudi Arabia1,41, Uni-
ted Arab Emirates1, Qatar1,16 and Bahrain1. It is also similar to
that in other MENA countries, beyond the Gulf region, such as
in Tunisia1,42 and Jordan1,17. Although this suggests that there
could be homogeneity in the underlying type 2 diabetes melli-
tus epidemiology in this region despite the differences in the
socioeconomic conditions across MENA countries, the underly-
ing demographic structures could be still different. For instance,
applying a similar mathematical modeling approach, type 2 dia-
betes mellitus prevalence in Qatar and Jordan was projected to
grow by 43 and 29% by 2050, respectively16,17, whereas the
type 2 diabetes mellitus prevalence in Oman was projected to
grow by 56%. These differences are explained in part by differ-
ences in the demographic structure of these populations.
The present study had limitations. First, the study did not
include the expatriate population of Oman, as this analysis was
intended for the permanent and stable population of this coun-
try. Expatriates residing in Oman are not permanent residents,
they come to Oman for work through work visas and not
immigrant visas, and most often stay for a limited number of
years. Furthermore, the national surveys9–15 that formed the
bulk of input data to our model did not include this transient
population of Oman, and thus cannot be included in our anal-
yses.
Second, the study did not account for other risk factors for
type 2 diabetes mellitus, such as gestational diabetes, diet and
hypertension. Although these risk factors were not explicitly
accounted for in the model, their impact on type 2 diabetes
mellitus prevalence and incidence is indirectly factored in the
‘baseline’ incidence rate; that is, in the part of the population
that is not obese, not a smoker and not physically inactive.
Thus, explicit inclusion of such factors would only change the
baseline incidence rate, but not likely to affect the projections
for the type 2 diabetes mellitus prevalence and incidence rate,
nor the estimated role of obesity, smoking and physical
inactivity.
Third, we used all national surveys carried out in Oman at
different time points, but such volume of evidence could result
in variations in the survey approach, time-point, design, geo-
graphic coverage, and methods used to ascertain diabetes melli-
tus and risk factors43,44. Outcome definitions, potential selection
and information biases, and response rates differed from one
survey to another43,44. Our projections, thus, are contingent on
the representativeness of these surveys. However, by factoring
in the totality of the type 2 diabetes mellitus surveys through
such a mathematical modeling approach, model fitting might
ensure best fit to data, accounting for adjustments/corrections
to these data, as well as weights for the level of confidence in
each survey data point – irrespective of the discrepancies and
limitations in available data.
Finally, the relative ratio of health expenditure for type 2 dia-
betes mellitus individuals versus non-type 2 diabetes mellitus
individuals was not age-dependent nor Oman-specific. How-
ever, to bracket the estimates of the type 2 diabetes mellitus
economic burden, we used the conventional range of 2–3 to be
consistent with the global empirical evidence25. The estimates
of the RRs of type 2 diabetes mellitus with respect to the risk
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factors and the RRs of disease-related mortality were obtained
from large, quality prospective studies that were pooled through
global systematic reviews and meta-analyses5–7, albeit the repre-
sentativeness of these RRs for the population of Oman is
unknown. However, given that these RRs were pooled from
multiple settings and they represent biological mechanisms that
are probably universal in their effect, variations in these RRs
might have a limited impact on the present results. Indeed, we
carried out several sensitivity analyses to assess the robustness
of our predictions to variations in these RRs. The analyses
showed that the present results were mainly sensitive to the RR
of developing type 2 diabetes mellitus if obese (Figure S10),
which is well established in the literature45,46. We also carried
out a multivariable uncertainty analysis to assess the robustness
of our predictions. The analysis indicated narrow uncertainty
intervals around the point estimates (Figure S11), affirming our
predictions.
In conclusion, the type 2 diabetes mellitus epidemic in
Oman is projected to substantially increase over the next three
decades, consuming a large proportion of the country’s national
health expenditure. The main driving factor for this increase is
the rising prevalence of obesity. Ensuring long-term financial
sustainability for type 2 diabetes mellitus response in Oman is
a concern, given the country’s high public budget contribution,
unstable revenues, and the ongoing demographic and epidemi-
ological health transitions. Therefore, the present findings high-
light the need for large-scale population-level interventions that
emphasize on type 2 diabetes mellitus prevention and that alle-
viate the burden of obesity.
Type 2 diabetes mellitus prevention should be implemented at
both national and governorate levels with multi-sectorial, govern-
mental and societal support, as type 2 diabetes mellitus is an
emerging threat to social and economic development. In addi-
tion, aiming at reducing the modifiable risk factors for type 2 dia-
betes mellitus, existing public awareness campaigns and
interventions need to be expanded by strengthening the imple-
mentation of Oman’s National Policy for Diet, Physical Activity
and Health36, and introducing legislation on foods and beverages.
Furthermore, implementation of the physical activity toolkit,
ACTIVE, launched by the World Health Organization47, could
be beneficial to encourage adoption of active lifestyles and to
reduce sedentary lifestyles. Finally, the country needs to stream-
line the health information systems to guarantee reliable, com-
plete, and quality data for evidence-based practice and decision-
making in type 2 diabetes mellitus prevention and control.
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